 | • レポートコード：MRC2206A025 • 出版社/出版日：Persistence Market Research / 2022年4月7日 • レポート形態：英文、PDF、380ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界の整形外科用プランニングシステム市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症による危機分析、主要成功要因、価格分析、需要分析・予測、ソリューション別（手術前プランニングシステム、手術後プランニングシステム）分析、用途別（整形外科手術、整形外科腫瘍研究）分析、展開別（Webベースソフトウェア、クラウドベースソフトウェア、オンプレミス）分析、エンドユーザー別（病院、外来手術センター、整形外科オフィス、クリニック）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・新型コロナウイルス感染症による危機分析 ・主要成功要因 ・価格分析 ・需要分析・予測 ・世界の整形外科用プランニングシステム市場規模：ソリューション別（手術前プランニングシステム、手術後プランニングシステム） ・世界の整形外科用プランニングシステム市場規模：用途別（整形外科手術、整形外科腫瘍研究） ・世界の整形外科用プランニングシステム市場規模：展開別（Webベースソフトウェア、クラウドベースソフトウェア、オンプレミス） ・世界の整形外科用プランニングシステム市場規模：エンドユーザー別（病院、外来手術センター、整形外科オフィス、クリニック） ・世界の整形外科用プランニングシステム市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Orthopedic Planning Systems Market – Scope of Report
The latest publication by Persistence Market Research on the global orthopedic planning systems market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for orthopedic planning systems and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the orthopedic planning systems market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the orthopedic planning systems market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the orthopedic planning systems market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the orthopedic planning systems market offers information divided into five important segments – solution, application, deployment, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Solution
Pre-Surgical Planning Software
2D Planning Software
3D Planning Software
Post-Surgical Planning Software
Application
Joint Replacement
Hip Replacement
Knee Replacement
Shoulder Replacement
Small Bone Replacement
Orthopedic Oncology
Deployment
Web-based Software
Cloud-based Software
On-premise
End User
Hospitals
Ambulatory Surgical Centers
Orthopedic Office-Based Clinics
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for orthopedic planning systems over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the orthopedic planning systems industry avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the orthopedic planning systems market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the orthopedic planning systems market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic factors
4.1.1. Global Healthcare Market Outlook
4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
4.1.3. U.S. per-Capita Healthcare Expenditure
4.2. Forecast Factors
4.2.1. Evaluation of Incremental Costs and Effectiveness
4.2.2. Increasing Spending on Healthcare Per Capita
4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
4.2.4. Application of biomedical and nanotechnology in Orthopaedics
4.3. Market Dynamics
4.3.1. Demand
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Supply Demand Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. COVID19 and Impact Analysis
5.2.1. By Solution
5.2.2. By Application
5.2.3. By Deployment
5.2.4. By End User
6. Key Success Factors
6.1. Key Developments
6.2. Regulatory Scenario
6.3. Key Deals and Contracts
6.4. Number of Surgeries, By Region
7. Global Orthopedic Planning Systems Market – Pricing Analysis
7.1. Country-wise & Regional Pricing Analysis, By Solution
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2016–2020 and Forecast, 2021–2031
8.1. Historical Market Value (US$ Mn) Analysis, 2016–2020
8.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031, by Solution
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2016–2020
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2021–2031
9.3.1. Orthopedic Planning Systems
9.3.1.1. Pre-Surgical Planning Software
9.3.1.1.1. 2D Planning Software
9.3.1.1.2. 3D Planning Software
9.3.1.2. Post-Surgical Planning Software
9.4. Market Attractiveness Analysis, By Solution
10. Global Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2016–2020
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2021–2031
10.3.1. Orthopedic Surgery
10.3.1.1. Joint Replacement
10.3.1.1.1. Hip Replacement
10.3.1.1.2. Knee Replacement
10.3.1.1.3. Shoulder Replacement
10.3.1.1.4. Small Bone Replacement
10.3.2. Orthopedic Oncology
10.4. Market Attractiveness Analysis, By Application
11. Global Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031, by Deployment
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2016–2020
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2021–2031
11.3.1. Web Based Software
11.3.2. Cloud Based Software
11.3.3. On Premises
11.4. Market Attractiveness Analysis, By Deployment
12. Global Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2016–2020
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2021–2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centres
12.3.3. Orthopedic Office-Based
12.3.4. Clinics
12.4. Market Attractiveness Analysis, By End User
13. Global Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2016–2020
13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2021–2031
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis, By Region
14. North America Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Solution
14.4.3. By Application
14.4.4. By Deployment
14.4.5. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Solution
14.5.3. By Application
14.5.4. By Deployment
14.5.5. By End User
14.6. Market Trends
14.7. Key Market Participants – Intensity Mapping
14.8. Drivers and Restraints – Impact Analysis
15. Latin America Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Solution
15.4.3. By Application
15.4.4. By Deployment
15.4.5. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Solution
15.5.3. By Application
15.5.4. By Deployment
15.5.5. By End User
15.6. Market Trends
15.7. Key Market Participants – Intensity Mapping
15.8. Drivers and Restraints – Impact Analysis
16. Europe Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Solution
16.4.3. By Application
16.4.4. By Deployment
16.4.5. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Solution
16.5.3. By Application
16.5.4. By Deployment
16.5.5. By End User
16.6. Market Trends
16.7. Key Market Participants – Intensity Mapping
16.8. Drivers and Restraints – Impact Analysis
17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
17.4.1. By Country
17.4.1.1. India
17.4.1.2. ASEAN
17.4.1.3. Oceania
17.4.1.4. Rest of South Asia & Pacific
17.4.2. By Solution
17.4.3. By Application
17.4.4. By Deployment
17.4.5. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Solution
17.5.3. By Application
17.5.4. By Deployment
17.5.5. By End User
17.6. Market Trends
17.7. Key Market Participants – Intensity Mapping
17.8. Drivers and Restraints – Impact Analysis
18. East Asia Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Solution
18.4.3. By Application
18.4.4. By Deployment
18.4.5. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Solution
18.5.3. By Application
18.5.4. By Deployment
18.5.5. By End User
18.6. Market Trends
18.7. Key Market Participants – Intensity Mapping
18.8. Drivers and Restraints – Impact Analysis
19. Oceania Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Solution
19.4.3. By Application
19.4.4. By Deployment
19.4.5. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Solution
19.5.3. By Application
19.5.4. By Deployment
19.5.5. By End User
19.6. Market Trends
19.7. Key Market Participants – Intensity Mapping
19.8. Drivers and Restraints – Impact Analysis
20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2016–2020 and Forecast 2021–2031
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2016–2020
20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2021–2031
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Turkey
20.4.1.3. Northern Africa
20.4.1.4. South Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Solution
20.4.3. By Application
20.4.4. By Deployment
20.4.5. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Solution
20.5.3. By Application
20.5.4. By Deployment
20.5.5. By End User
20.6. Market Trends
20.7. Key Market Participants – Intensity Mapping
20.8. Drivers and Restraints – Impact Analysis
21. Country Level Orthopedic Planning Systems Market Analysis 2021-2031
21.1. Introduction
21.1.1. Market Value Proportion Analysis
21.1.2. Global VS. Country Growth Comparison
21.1.3. Pricing Analysis, by Country
21.2. U.S. Orthopedic Planning Systems Market Analysis
21.2.1. By Solution
21.2.2. By Application
21.2.3. By Deployment
21.2.4. By End User
21.3. Canada Orthopedic Planning Systems Market Analysis
21.3.1. By Solution
21.3.2. By Application
21.3.3. By Deployment
21.3.4. By End User
21.4. Mexico Orthopedic Planning Systems Market Analysis
21.4.1. By Solution
21.4.2. By Application
21.4.3. By Deployment
21.4.4. By End User
21.5. Brazil Orthopedic Planning Systems Market Analysis
21.5.1. By Solution
21.5.2. By Application
21.5.3. By Deployment
21.5.4. By End User
21.6. Germany Orthopedic Planning Systems Market Analysis
21.6.1. By Solution
21.6.2. By Application
21.6.3. By Deployment
21.6.4. By End User
21.7. Italy Orthopedic Planning Systems Market Analysis
21.7.1. By Solution
21.7.2. By Application
21.7.3. By Deployment
21.7.4. By End User
21.8. France Orthopedic Planning Systems Market Analysis
21.8.1. By Solution
21.8.2. By Application
21.8.3. By Deployment
21.8.4. By End User
21.9. U.K. Orthopedic Planning Systems Market Analysis
21.9.1. By Solution
21.9.2. By Application
21.9.3. By Deployment
21.9.4. By End User
21.10. Spain Orthopedic Planning Systems Market Analysis
21.10.1. By Solution
21.10.2. By Application
21.10.3. By Deployment
21.10.4. By End User
21.11. Russia Orthopedic Planning Systems Market Analysis
21.11.1. By Solution
21.11.2. By Application
21.11.3. By Deployment
21.11.4. By End User
21.12. China Orthopedic Planning Systems Market Analysis
21.12.1. By Solution
21.12.2. By Application
21.12.3. By Deployment
21.12.4. By End User
21.13. Japan Orthopedic Planning Systems Market Analysis
21.13.1. By Solution
21.13.2. By Application
21.13.3. By Deployment
21.13.4. By End User
21.14. S. Korea Orthopedic Planning Systems Market Analysis
21.14.1. By Solution
21.14.2. By Application
21.14.3. By Deployment
21.14.4. By End User
21.15. India Orthopedic Planning Systems Market Analysis
21.15.1. By Solution
21.15.2. By Application
21.15.3. By Deployment
21.15.4. By End User
21.16. ASEAN Orthopedic Planning Systems Market Analysis
21.16.1. By Solution
21.16.2. By Application
21.16.3. By Deployment
21.16.4. By End User
21.17. Australia Orthopedic Planning Systems Market Analysis
21.17.1. By Solution
21.17.2. By Application
21.17.3. By Deployment
21.17.4. By End User
21.18. New Zealand Orthopedic Planning Systems Market Analysis
21.18.1. By Solution
21.18.2. By Application
21.18.3. By Deployment
21.18.4. By End User
21.19. Turkey Orthopedic Planning Systems Market Analysis
21.19.1. By Solution
21.19.2. By Application
21.19.3. By Deployment
21.19.4. By End User
21.20. South Africa Orthopedic Planning Systems Market Analysis
21.20.1. By Solution
21.20.2. By Application
21.20.3. By Deployment
21.20.4. By End User
22. Market Structure Analysis
22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
22.3.1. By Regional footprint of Players
22.3.2. Device foot print by Players
22.3.3. Channel Foot Print by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. Formus Labs Ltd
23.3.1.1. Overview & Key financials
23.3.1.2. Product Portfolio
23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
23.3.1.4. SWOT Analysis
23.3.1.5. Sales Footprint
23.3.1.6. Strategy Overview
23.3.1.7. Sales and Marketing strategies
23.3.1.8. Channel Strategies
23.3.2. EOS imaging
23.3.2.1. Overview & Key financials
23.3.2.2. Product Portfolio
23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
23.3.2.4. SWOT Analysis
23.3.2.5. Sales Footprint
23.3.2.6. Strategy Overview
23.3.2.7. Sales and Marketing strategies
23.3.2.8. Channel Strategies
23.3.3. Brainlab AG
23.3.3.1. Overview & Key financials
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
23.3.3.4. SWOT Analysis
23.3.3.5. Sales Footprint
23.3.3.6. Strategy Overview
23.3.3.7. Sales and Marketing strategies
23.3.3.8. Channel Strategies
23.3.4. Sectra AB
23.3.4.1. Overview & Key financials
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
23.3.4.4. SWOT Analysis
23.3.4.5. Sales Footprint
23.3.4.6. Strategy Overview
23.3.4.7. Sales and Marketing strategies
23.3.4.8. Channel Strategies
23.3.5. Stryker
23.3.5.1. Overview & Key financials
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
23.3.5.4. SWOT Analysis
23.3.5.5. Sales Footprint
23.3.5.6. Strategy Overview
23.3.5.7. Sales and Marketing strategies
23.3.5.8. Channel Strategies
23.3.6. Materialise
23.3.6.1. Overview & Key financials
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
23.3.6.4. SWOT Analysis
23.3.6.5. Sales Footprint
23.3.6.6. Strategy Overview
23.3.6.7. Sales and Marketing strategies
23.3.6.8. Channel Strategies
23.3.7. Medstrat
23.3.7.1. Overview & Key financials
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
23.3.7.4. SWOT Analysis
23.3.7.5. Sales Footprint
23.3.7.6. Strategy Overview
23.3.7.7. Sales and Marketing strategies
23.3.7.8. Channel Strategies
23.3.8. MediCAD Hectec GmbH
23.3.8.1. Overview & Key financials
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
23.3.8.4. SWOT Analysis
23.3.8.5. Sales Footprint
23.3.8.6. Strategy Overview
23.3.8.7. Sales and Marketing strategies
23.3.8.8. Channel Strategies
23.3.9. 3D Systems, Inc
23.3.9.1. Overview & Key financials
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
23.3.9.4. SWOT Analysis
23.3.9.5. Sales Footprint
23.3.9.6. Strategy Overview
23.3.9.7. Sales and Marketing strategies
23.3.9.8. Channel Strategies
23.3.10. PEEK HEALTH S.A
23.3.10.1. Overview & Key financials
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
23.3.10.4. SWOT Analysis
23.3.10.5. Sales Footprint
23.3.10.6. Strategy Overview
23.3.10.7. Sales and Marketing strategies
23.3.10.8. Channel Strategies
23.3.11. Radlink, Inc.
23.3.11.1. Overview & Key financials
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
23.3.11.4. SWOT Analysis
23.3.11.5. Sales Footprint
23.3.11.6. Strategy Overview
23.3.11.7. Sales and Marketing strategies
23.3.11.8. Channel Strategies
23.3.12. SurgiNovi
23.3.12.1. Overview & Key financials
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
23.3.12.4. SWOT Analysis
23.3.12.5. Sales Footprint
23.3.12.6. Strategy Overview
23.3.12.7. Sales and Marketing strategies
23.3.12.8. Channel Strategies
23.3.13. RSA Biomedical
23.3.13.1. Overview & Key financials
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
23.3.13.4. SWOT Analysis
23.3.13.5. Sales Footprint
23.3.13.6. Strategy Overview
23.3.13.7. Sales and Marketing strategies
23.3.13.8. Channel Strategies
23.3.14. HIPOP-PLAN
23.3.14.1. Overview & Key financials
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
23.3.14.4. SWOT Analysis
23.3.14.5. Sales Footprint
23.3.14.6. Strategy Overview
23.3.14.7. Sales and Marketing strategies
23.3.14.8. Channel Strategies
23.3.15. Zimmer Biomet.
23.3.15.1. Overview & Key financials
23.3.15.2. Product Portfolio
23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
23.3.15.4. SWOT Analysis
23.3.15.5. Sales Footprint
23.3.15.6. Strategy Overview
23.3.15.7. Sales and Marketing strategies
23.3.15.8. Channel Strategies
23.3.16. Optinav
23.3.16.1. Overview & Key financials
23.3.16.2. Product Portfolio
23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
23.3.16.4. SWOT Analysis
23.3.16.5. Sales Footprint
23.3.16.6. Strategy Overview
23.3.16.7. Sales and Marketing strategies
23.3.16.8. Channel Strategies
23.3.17. Enhatch Inc.
23.3.17.1. Overview & Key financials
23.3.17.2. Product Portfolio
23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
23.3.17.4. SWOT Analysis
23.3.17.5. Sales Footprint
23.3.17.6. Strategy Overview
23.3.17.7. Sales and Marketing strategies
23.3.17.8. Channel Strategies
23.3.18. Numex GmbH
23.3.18.1. Overview & Key financials
23.3.18.2. Product Portfolio
23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
23.3.18.4. SWOT Analysis
23.3.18.5. Sales Footprint
23.3.18.6. Strategy Overview
23.3.18.7. Sales and Marketing strategies
23.3.18.8. Channel Strategies
23.3.19. Corin Group
23.3.19.1. Overview & Key financials
23.3.19.2. Product Portfolio
23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
23.3.19.4. SWOT Analysis
23.3.19.5. Sales Footprint
23.3.19.6. Strategy Overview
23.3.19.7. Sales and Marketing strategies
23.3.19.8. Channel Strategies
24. Assumptions and Acronyms Used
25. Research Methodology
Table 1: Key DevelopmentsTable 2: Key Developments
Table 3: Key Developments
Table 4: Key Developments
Table 5: Key Developments
Table 6: Key Developments
Table 7: Key Developments
Table 8: Key Developments
Table 9: Key Developments
Table 10: Key Developments
Table 11: Key Deals and contract
Table 12: Key Deals and contract
Table 13: Global Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 14: Global Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 15: Global Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 16: Global Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 17: Global Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
Table 18: North America Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 19: North America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 20: North America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 21: North America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 22: North America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 23: Latin America Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 24: Latin America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 25: Latin America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 26: Latin America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 27: Latin America Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 28: Europe Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 29: Europe Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 30: Europe Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 31: Europe Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 32: Europe Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 33: South Asia Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 34: South Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 35: South Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 36: South Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 37: South Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 38: East Asia Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 39: East Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 40: East Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 41: East Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 42: East Asia Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 43: Oceania Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 44: Oceania Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 45: Oceania Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 46: Oceania Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 47: Oceania Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User
Table 48: MEA Orthopedic Planning Systems Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031
Table 49: MEA Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Solution
Table 50: MEA Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application
Table 51: MEA Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Deployment
Table 52: MEA Orthopedic Planning Systems Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User